Addressing patients with chronic kidney disease requires a commitment to data, education, and community, specifically in those affected by social determinants of health (SDOH).

March is National Kidney Month — a chance to highlight kidney disease and the impact it has on patient in their doctor’s ...

These signs pointed to a severe autoimmune kidney disorder known as Pauci-immune Crescentic Glomerulonephritis, a rare subtype of Rapidly Progressive Glomerulonephritis (RPGN), a condition that can ...

The use of technicians to assist in delivering dialysis to the end-stage kidney disease population has been a recognized role ...

Novartis' Fabhalta receives FDA approval for C3 glomerulopathy, expanding its kidney disease portfolio as global regulatory ...

Study findings support the monitoring and management of iron status in patients with early stages of chronic kidney disease (CKD).

Investigators assessed frailty prevalence in a nationally representative US cohort and inpatient outcomes among kidney transplant recipients.

In patients with CKD, hyperkalemia significantly increases risk for major adverse cardiovascular events and arrhythmia.

AUSTIN – The Texas Health and Human Services Commission is highlighting resources for kidney disease patients and encouraging people to consider joining the organ donor registry as part of National ...

Nearly 10% of Indians suffer from some kind of kidney malfunction, making chronic kidney disease (CKD) a rising public health ...

The FDA on Thursday approved Fabhalta (iptacopan) to treat complement 3 glomerulopathy (CG3), a progressive, ultrarare kidney ...